Edition:
United States

Halozyme Therapeutics Inc (HALO.O)

HALO.O on Nasdaq

11.37USD
2 Dec 2016
Change (% chg)

$0.14 (+1.25%)
Prev Close
$11.23
Open
$11.21
Day's High
$11.56
Day's Low
$11.08
Volume
886,098
Avg. Vol
1,510,492
52-wk High
$18.25
52-wk Low
$6.96

Select another date:

Mon, Nov 7 2016

BRIEF-Halozyme reports Q3 loss per share $0.23

* Q3 earnings per share view $-0.27 -- Thomson Reuters I/B/E/S

BRIEF-Halozyme reports second quarter 2016 financial results

* Q2 earnings per share view $-0.27 -- Thomson Reuters I/B/E/S

BRIEF-Halozyme to resume enrollment in Phase 1B trial evaluating PEGPH20

* Resumed enrollment, dosing patients in phase 1B trial evaluating investigational new drug, PEGPH20, in combination with KEYTRUDA

BRIEF-Halozyme announces agreement to refinance debt

* Entered into agreement with Oxford Finance Llc and Silicon Valley Bank to refinance its existing senior secured loan facility

Select another date: